Apalutamide‐associated skin rash in patients with prostate cancer: Histological evaluation by skin biopsy
Authors:
Open Access
- 27 June 2021
- journal article
- case report
- Published by Wiley in IJU Case Reports
- Vol. 4 (5) , 299-302
Abstract
Introduction: Apalutamide‐associated skin rash is a more common adverse event in the Japanese population than in the global population. However, its mechanism remains elusive, and limited histopathological information hampers further understanding.Case presentation: Case 1: a 71‐year‐old man with metastatic castration‐sensitive prostate cancer developed a skin rash after 70 days of apalutamide treatment. Case 2: a 71‐year‐old man with non‐metastatic castration‐resistant prostate cancer developed a skin rash after 71 days of apalutamide treatment. In both cases, the skin rash presented as a slightly exudative erythema. The histology showed spongiosis of the epidermis and perivascular and interstitial infiltration of lymphocytes and eosinophils in the upper dermis without necrotic keratinocytes.Conclusion: Apalutamide‐induced skin rashes can involve an eczematous reaction clinically and histologically.Keywords
This publication has 11 references indexed in Scilit:
- Apalutamide and Overall Survival in Prostate CancerEuropean Urology, 2021
- Efficacy and safety of apalutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a subgroup analysis of a randomized, double-blind, placebo-controlled, Phase-3 studyProstate International, 2020
- Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label studyBMC Urology, 2020
- Efficacy and Safety Exposure–Response Relationships of Apalutamide in Patients with Nonmetastatic Castration-Resistant Prostate CancerClinical Cancer Research, 2020
- Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drugThe Journal of Dermatology, 2020
- Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy ModelChemical Research in Toxicology, 2019
- Apalutamide for Metastatic, Castration-Sensitive Prostate CancerNew England Journal of Medicine, 2019
- Histopathological study of six types of adverse cutaneous drug reactions using granulysin expressionInternational Journal of Dermatology, 2016
- Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?British Journal of Dermatology, 2007
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981